Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 3/20 | 0.45 |
| ▸ | RAB9A | P51151 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | XDH | P47989 | 2/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | PDE5A | O76074 | 1/20 | 0.40 |
| ▸ | PDE1A | P54750 | 1/20 | 0.40 |
| ▸ | PDE1B | Q01064 | 1/20 | 0.40 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.40 |
| ▸ | PDE1C | Q14123 | 1/20 | 0.40 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL956335 | 0.82 | HPGD (0.60) | HPGDLMNASMN1; SMN2CYP2C19CYP1A2 | |
| Tazanolast SCHEMBL1651344 | 0.82 | MAPT (0.61) | HPGDRAB9ALMNACYP2C19NPC1 | |
| SCHEMBL950001 | 0.79 | CYP3A4 (0.60) | HPGDRAB9ALMNASMN1; SMN2CYP2C19 | |
| Acitazanolast SCHEMBL342549 | 0.79 | GPR35 (0.54) | HPGDRAB9ASMN1; SMN2NPC1TSHR | |
| Acitazanolast SCHEMBL3116621 | 0.78 | GPR35 (0.53) | HPGDRAB9ASMN1; SMN2NPC1TSHR | |
| SCHEMBL6694019 | 0.77 | MAPT (0.59) | HPGDRAB9ASMN1; SMN2NPC1CYP1A2 | |
| SCHEMBL22167182 | 0.77 | MGLL (0.54) | LMNAMAPTKMT2ACDK8 | |
| SCHEMBL9314587 | 0.76 | MGLL (0.45) | HPGDRAB9ASMN1; SMN2CYP2C19NPC1 | |
| SCHEMBL11647389 | 0.75 | HPGD (0.76) | HPGDRAB9ALMNASMN1; SMN2CYP2C19 | |
| SCHEMBL8947313 | 0.75 | MAPT (0.44) | HPGDRAB9ALMNASMN1; SMN2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1093 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3400971-B1 | ABSORBABLE IRON-BASED ALLOY IMPLANTABLE MEDICAL DEVICE | BIOTYX MEDICAL SHENZHEN CO LTD (CN) | 2021-08-04 | — | — | EP | claimed |
| EP-3400969-B1 | IMPLANTED DEVICE | BIOTYX MEDICAL SHENZHEN CO LTD (CN) | 2021-05-19 | — | — | EP | claimed |
| US-10946121-B2 | Absorbable iron-based alloy implantable medical device | BIOTYX MEDICAL (SHENZHEN) CO., LTD. (CN) | 2021-03-16 | — | — | US | claimed |
| EP-3400970-B1 | ABSORBABLE IRON-BASED ALLOY MEDICAL DEVICE IMPLANT | LIFETECH SCIENT SHENZHEN CO (CN) | 2021-03-03 | — | — | EP | claimed |
| US-20200215237-A1 | ABSORBABLE IRON-BASED ALLOY IMPLANTABLE MEDICAL DEVICE | BIOTYX MEDICAL (SHENZHEN) CO., LTD. (CN) | 2020-07-09 | — | — | US | claimed |
| EP-2913062-B1 | THERAPEUTIC OR PROPHYLACTIC AGENT FOR RETINOPATHY OF PREMATURITY AND METHOD OF TESTING FOR RETINOPATHY OF PREMATURITY | JAPAN INNOVATIVE THERAPEUTICS INC (JP) | 2019-05-08 | — | — | EP | claimed |
| US-20190022284-A1 | Absorbable Iron-based Alloy Medical Device Implant | LIFETECH SCIENTIFIC (SHENZHEN) CO., LTD. (CN) | 2019-01-24 | — | — | US | claimed |
| US-20190008996-A1 | Implanted Device | LIFETECH SCIENTIFIC (SHENZHEN) CO., LTD. (CN) | 2019-01-10 | — | — | US | claimed |
| EP-3400969-A1 | IMPLANTED DEVICE | Lifetech Scientific (Shenzhen) Co., Ltd. (CN) | 2018-11-14 | — | — | EP | claimed |
| EP-3400971-A1 | ABSORBABLE IRON-BASED ALLOY IMPLANTABLE MEDICAL DEVICE | Lifetech Scientific (Shenzhen) Co., Ltd. (CN) | 2018-11-14 | — | — | EP | claimed |
| US-20060018933-A1 | Novel drug delivery system | TORRENT PHARMACEUTICALS LIMITED (IN) | 2006-01-26 | — | — | US | claimed |
| US-20040247628-A1 | Kit for the preparation of a pharmaceutical composition | PARI PHARMA GMBH (DE) | 2004-12-09 | — | — | US | claimed |
| EP-1438019-A1 | KIT FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION | PARI GmbH Spezialisten für effektive Inhalation (DE) | 2004-07-21 | — | — | EP | claimed |
| EP-1336602-A1 | Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases | Scaramuzzino, Giovanni (IT) | 2003-08-20 | — | — | EP | claimed |
| WO-2003035030-A1 | KIT FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION | PARI GMBH (DE) | 2003-05-01 | — | — | WO | claimed |
| US-5811547-A | Method for inducing crystalline state transition in medicinal substance | NIPPON SHINYAJU CO., LTD. (JP) | 1998-09-22 | — | — | US | claimed |
| US-5693337-A | OIL IN WATER EMULSION CONTAINING DRUG, LECITHIN, CITRIC ACID, AND METHIONINE, PHENYLALANINE, SERINE, AND/OR HISTIDINE; SYNERGISTIC, STORAGE STABILITY | WAKAMOTO PHARMACEUTICAL CO., LTD. (JP) | 1997-12-02 | — | — | US | claimed |
| EP-0700678-A1 | Stable lipid emulsion | Wakamoto Pharmaceutical Co., Ltd. (JP) | 1996-03-13 | — | — | EP | claimed |
| EP-0481118-B1 | A method for producing butyl 3'-(1H-tetrazol-5-yl) oxanilate | WAKAMOTO PHARMA CO LTD (JP) | 1995-08-02 | — | — | EP | claimed |
| US-4778816-A | MIXING THE TETRAZOLE WITH DISPERSANT AND NONAQUEOUS SOLVENT; DESOLVENTIZING | WAKAMOTO PHARMACEUTICAL CO., LTD. (JP) | 1988-10-18 | — | — | US | claimed |